[HTML][HTML] Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts

J Mondet, S Chevalier, P Mossuz - Molecules, 2021 - mdpi.com
Deregulations of the expression of the S100A8 and S100A9 genes and/or proteins, as well
as changes in their plasma levels or their levels of secretion in the bone marrow …

Liquid biopsy technologies for hematological diseases

Y Fu, Y Zhang, BL Khoo - Medicinal Research Reviews, 2021 - Wiley Online Library
Since the discovery of circulating tumor cells in 1869, technological advances in studying
circulating biomarkers from patients' blood have made the diagnosis of nonhematologic …

[HTML][HTML] Drug resistance biomarkers and their clinical applications in childhood acute lymphoblastic leukemia

N Aberuyi, S Rahgozar, ES Ghodousi… - Frontiers in oncology, 2020 - frontiersin.org
Biomarkers are biological molecules found in body fluids or tissues, which can be
considered as indications of a normal or abnormal process, or of a condition or disease …

[HTML][HTML] A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia

MS Cavalcante, JC Torres-Romero, MDP Lobo… - Biomarker …, 2016 - Springer
Background Acute lymphoblastic leukemia is the most common malignant cancer in
childhood. The signs and symptoms of childhood cancer are difficult to recognize, as it is not …

[HTML][HTML] Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer

P Arner, F Henjes, JM Schwenk, S Darmanis… - PloS one, 2015 - journals.plos.org
Background Cancer cachexia (CC) is linked to poor prognosis. Although the mechanisms
promoting this condition are not known, several circulating proteins have been proposed to …

Children as biomarker orphans: progress in the field of pediatric biomarkers

DR Shores, AD Everett - The Journal of pediatrics, 2018 - jpeds.com
Biomarkers are incorporated ubiquitously into clini-cal practice as surrogate endpoints of
physiologic and pathologic processes that cannot be measured directly. For example, a lipid …

[HTML][HTML] Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities

M Kourti, M Aivaliotis, E Hatzipantelis - Diagnostics, 2023 - mdpi.com
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and one of the
success stories in cancer therapeutics. Risk-directed therapy based on clinical, biologic and …

[HTML][HTML] Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model

Z Nagy, K Baghy, É Hunyadi-Gulyás… - American Journal of …, 2015 - ncbi.nlm.nih.gov
The available drug treatment options for adrenocortical carcinoma (ACC) are limited. In our
previous studies, the in vitro activity of 9-cis retinoic acid (9-cisRA) on adrenocortical NCI …

[HTML][HTML] Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia

CD Álvarez-Zúñiga, I Garza-Veloz, J Martínez-Rendón… - Cancers, 2023 - mdpi.com
Simple Summary Acute lymphoblastic leukemia (ALL) is a hematological disease
characterized by the malfunction of the hematopoietic system. This process is generated and …

Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches

C Jiménez, A Garrote-de-Barros… - International Journal of …, 2024 - mdpi.com
The maturation of B cells is a complex, multi-step process. During B cell differentiation,
errors can occur, leading to the emergence of aberrant versions of B cells that, finally …